Skip to main content
Premium Trial:

Request an Annual Quote

Personalis, Garvan Institute to Provide Genome Sequencing, Analysis to Researchers, Clinicians

NEW YORK (GenomeWeb) – Personalis and the Garvan Institute of Medical Research said today that they have partnered to provide commercial human whole-genome sequencing, analysis, and interpretation services to researchers and clinicians worldwide.

The partners will use the sequencing platform and expertise from the Garvan Institute, based in Sydney, Australia, and the pipeline, expertise, and infrastructure to analyze, annotate, and interpret the data from Personalis, located in Menlo Park, Calif.

The Garvan's Kinghorn Centre for Clinical Genomics recently purchased the HiSeq X Ten sequencing system from Illumina, allowing it to sequence more than 350 human genomes per week. The institute plans to undertake clinical research projects and ultimately to provide clinical-grade genome sequencing for diagnostic purposes.

"This agreement will accelerate the pace of scientific research and clinical diagnosis by facilitating rapid, comprehensive and accurate whole genome sequencing combined with high-quality analysis and easy-to-interpret reports for large projects involving human data," Personalis CEO John West said in a statement.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.